Cirrhosis

Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis

H. B. Xu, Wang, H. D., Li, C. H., Ye, S., Dong, M. S., Xia, Q. J., Zhang, A. Q., Pan, K., Ge, X. L., and Dong, J. H., Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis, vol. 14, pp. 7490-7501, 2015.

We used a meta-analysis approach to investigate the association between proton pump inhibitor (PPI) use and risk of spontaneous bacterial peritonitis (SBP) in cirrhotic patients. We searched Ovid Medline, Embase, and the Cochrane Library to identify eligible studies. We included studies that compared cirrhotic patients who did or did not use PPIs. The primary outcome was SBP, and the secondary outcome was overall bacterial infection. Results were pooled using random-effect models. This process led to identification of 12 journal articles and 5 conference abstracts.

Reduced cortisol in the absence of bacterial infection in patients with hepatitis B virus cirrhosis

J. Zhang, Yu, H. - W., Li, J., Zhu, Y. - K., Wang, K. - F., Jia, L., and Meng, Q. - H., Reduced cortisol in the absence of bacterial infection in patients with hepatitis B virus cirrhosis, vol. 14, pp. 7957-7963, 2015.

In liver cirrhosis with bacterial infection, hepatoadrenal syndrome has been described recently as a progressive impairment in the adrenocortical reserve, with deficient production or action of glucocorticoids resulting in adrenal insufficiency. The aim of this study was to explore the characteristics of cortisol in hepatitis B virus (HBV) cirrhosis patients in the absence of bacterial infection.

Subscribe to Cirrhosis